Church & Dwight Acquires Matrixx Initiatives (Zicam) from Gryphon Investors
December 1, 2020
Church & Dwight Co., Inc. acquired Matrixx Initiatives, the maker of the Zicam over-the-counter cold remedy brand, from Gryphon Investors. The transaction, completed in December 2020, expands Church & Dwight’s consumer health portfolio and brings the Zicam brand and related product lines into its CPG portfolio (deal value reported at $530 million).
- Buyers
- Church & Dwight Co., Inc.
- Targets
- Matrixx Initiatives, Inc.
- Sellers
- Gryphon Investors
- Industry
- Consumer Products
- Location
- New Jersey, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Church & Dwight Acquires Miss Mouth's Messy Eater Brand for About $325 Million
May 29, 2026
Consumer Products
Church & Dwight Co., Inc. has signed and closed a definitive agreement to acquire the Miss Mouth's Messy Eater brand for approximately $325 million. The acquisition adds a digitally native, non-toxic stain-removal brand to Church & Dwight’s Fabric Care portfolio, with Miss Mouth's generating about $80 million in net sales and $28 million in EBITDA for the 12 months ended December 31, 2025.
-
Gryphon Investors Acquires AirX Climate Solutions from L Catterton
September 27, 2023
Industrial Services
Gryphon Investors has agreed to acquire AirX Climate Solutions (ACS), a specialty HVAC designer, manufacturer, distributor, and servicer headquartered in Oklahoma City, from private equity firm L Catterton. Gryphon will partner with ACS management, who are reinvesting, to expand geographic footprint, grow aftermarket and service offerings, and pursue add-on acquisitions; the deal is expected to close in Q4 2023 and financial terms were not disclosed.
-
Church & Dwight to Acquire Hero Mighty Patch Brand for $630 Million
September 6, 2022
Healthcare Services
Church & Dwight Co., Inc. has signed a definitive agreement to acquire the Hero Mighty Patch brand and other acne treatment products for $630 million, paid in cash and Church & Dwight restricted stock. The deal is subject to customary closing conditions and is expected to close in the fourth quarter.
-
Carlin Consumer Health Acquires Zegerid OTC from Bayer
February 1, 2022
Pharmaceuticals
Hildred Capital, Bourne Partners Strategic Capital and The Emerson Group launched Carlin Consumer Health and acquired the Zegerid OTC brand from Bayer AG to establish a consumer health/OTC platform. The investors plan to invest in marketing, sales and product development to grow the Zegerid brand across U.S. retail channels; financial terms were not disclosed.
-
Church & Dwight Completes Acquisition of TheraBreath
December 27, 2021
Consumer Products
Church & Dwight Co., Inc. has completed its previously announced acquisition of TheraBreath for $580 million in cash. The purchase adds the #2 alcohol-free mouthwash brand in the U.S. to Church & Dwight's oral care portfolio and strengthens its position in the mouthwash category.
-
Gryphon Investors Acquires Metagenics from Alticor
December 1, 2021
Consumer Products
Gryphon Investors signed a definitive agreement to acquire Metagenics, Inc. from Alticor, with the transaction expected to close in Q4 2021. WhiteHorse Capital provided a first-lien credit facility to Meta Buyer, LLC to support the acquisition; Gryphon will partner with Metagenics' management to invest in global growth, including potential strategic acquisitions.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.